Veracyte (VCYT) Net Cash Flow (2016 - 2026)
Veracyte's Net Cash Flow history spans 14 years, with the latest figure at $47.0 million for Q4 2025.
- On a quarterly basis, Net Cash Flow rose 237.73% to $47.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $122.9 million, a 417.92% increase, with the full-year FY2025 number at $122.9 million, up 417.92% from a year prior.
- Net Cash Flow hit $47.0 million in Q4 2025 for Veracyte, down from $96.0 million in the prior quarter.
- Over the last five years, Net Cash Flow for VCYT hit a ceiling of $96.0 million in Q3 2025 and a floor of -$163.6 million in Q3 2021.
- Historically, Net Cash Flow has averaged $795350.0 across 5 years, with a median of $10.2 million in 2021.
- Biggest five-year swings in Net Cash Flow: surged 352.74% in 2023 and later crashed 661.51% in 2025.
- Tracing VCYT's Net Cash Flow over 5 years: stood at $9.0 million in 2021, then tumbled by 284.33% to -$16.6 million in 2022, then surged by 182.55% to $13.7 million in 2023, then crashed by 349.1% to -$34.1 million in 2024, then skyrocketed by 237.73% to $47.0 million in 2025.
- Business Quant data shows Net Cash Flow for VCYT at $47.0 million in Q4 2025, $96.0 million in Q3 2025, and $32.8 million in Q2 2025.